World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
12466
World Ranking
2875
National Ranking
38

Karine Breckpot publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Karine Breckpot sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 223 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Karine Breckpot D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Karine Breckpot sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Karine Breckpot is affiliated with Vrije Universiteit Brussel in Belgium. Their research spans multiple fields within biomedical sciences, with a focus on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology.

Their work covers a variety of subfields including Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Genetics.

Key topics of their research include:

  • Immunotherapy and Immune Responses
  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • RNA Interference and Gene Delivery
  • Radiopharmaceutical Chemistry and Applications

Karine Breckpot's frequent co-authors have included:

  • Nick Devoogdt
  • Cleo Goyvaerts
  • Marleen Keyaerts
  • Kim De Veirman
  • Thomas Ertveldt

Their publications have appeared predominantly in venues such as:

  • Frontiers in Immunology
  • International Journal of Molecular Sciences
  • Journal of Nuclear Medicine
  • Journal of Controlled Release
  • Journal for ImmunoTherapy of Cancer

Among their recent papers are:

  • "Immunogenicity Risk Profile of Nanobodies" (2021, Frontiers in Immunology)
  • "The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm" (2020, International Journal of Molecular Sciences)
  • "Challenges in neoantigen-directed therapeutics" (2022, Cancer Cell)
  • "mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells" (2022, Molecular Therapy)
  • "Neo-Antigen mRNA Vaccines" (2020, Vaccines)

Best Publications

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Lentiviral vectors in gene therapy: their current status and future potential.

    David Escors;Karine Breckpot;Karine Breckpot

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Combinatorial Strategies for the Induction of Immunogenic Cell Death

    Lucillia Bezu;Ligia C. Gomes-de-Silva;Heleen Dewitte;Karine Breckpot

  • PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.

    Maria Gato-Cañas;Miren Zuazo;Hugo Arasanz;Maria Ibañez-Vea

  • Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages

    Kiavash Movahedi;Steve Schoonooghe;Damya Laoui;Isabelle Houbracken

  • PD1 signal transduction pathways in T cells

    Hugo Arasanz;Maria Gato-Cañas;Miren Zuazo;Maria Ibañez-Vea

  • CD83 expression on dendritic cells and T cells: correlation with effective immune responses.

    Cindy Aerts-Toegaert;Carlo Heirman;Sandra Tuyaerts;Jurgen Corthals

  • Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

    Aude Bonehill;Carlo Heirman;Sandra Tuyaerts;Annelies Michiels

  • Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

    Sandra Van Lint;Cleo Goyvaerts;Sarah Maenhout;Lode Goethals

  • Current approaches in dendritic cell generation and future implications for cancer immunotherapy.

    Sandra Tuyaerts;Joeri L. Aerts;Jurgen Corthals;Bart Neyns

  • Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.

    Karine Breckpot;Melissa Dullaers;Aude Bonehill;Sonja Van Meirvenne

  • Role of non-classical MHC class I molecules in cancer immunosuppression

    Grazyna Kochan;David Escors;Karine Breckpot;David Guerrero-Setas

  • Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression

    Robin Maximilian Awad;Yannick De Vlaeminck;Johannes Maebe;Cleo Goyvaerts

  • mRNA-based dendritic cell vaccines

    Daphné Benteyn;Carlo Heirman;Aude Bonehill;Kris Thielemans

  • Immunogenicity Risk Profile of Nanobodies

    Chloé Ackaert;Natalia Smiejkowska;Catarina Xavier;Yann G J Sterckx;Yann G J Sterckx

  • Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.

    Karine Breckpot;Joeri Aerts;Kris Thielemans

  • mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells

    Unknown

  • HIV-1 Lentiviral vector immunogenicity is mediated by Toll-Like Receptor 3 (TLR3) and TLR7

    Karine Breckpot;David Escors;Frederick Arce;Lucienne Lopes

  • Generation of large numbers of dendritic cells in a closed system using Cell Factories.

    Sandra Tuyaerts;Sofie M. Noppe;Jurgen Corthals;Karine Breckpot

  • Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission

    Marleen Keyaerts;Jacob Verschueren;Tomas J. Bos;Lea Olive Tchouate-Gainkam

Frequent Co-Authors

Carlo Heirman
Carlo Heirman Vrije Universiteit Brussel
Kris Thielemans
Kris Thielemans Vrije Universiteit Brussel
Geert Raes
Geert Raes Vrije Universiteit Brussel
Stefaan C. De Smedt
Stefaan C. De Smedt Ghent University
Patrick De Baetselier
Patrick De Baetselier Vrije Universiteit Brussel
Jo A. Van Ginderachter
Jo A. Van Ginderachter Vrije Universiteit Brussel
Karin Vanderkerken
Karin Vanderkerken Vrije Universiteit Brussel
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Serge Muyldermans
Serge Muyldermans Vrije Universiteit Brussel
Guido Kroemer
Guido Kroemer Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways in medical and clinical settings. Nursing professions, especially Licensed Practical Nurse (LPN) programs, provide foundational healthcare knowledge that complements immunology expertise. If you’re considering this route, reviewing the best easiest lpn programs to get into can help you find accessible options to start your nursing education.

Moving beyond LPN, many pursue Nurse Practitioner (NP) degrees that offer more advanced clinical roles. Identifying the what is the easiest np program is a great way to find programs that balance rigorous training with manageable entry requirements, ideal for immunology graduates aiming for patient-centered care.

In particular, the Psychiatric Mental Health Nurse Practitioner (PMHNP) specialization aligns well with immunology, especially for those interested in neuroimmunology or mental health intersections. Exploring top pmhnp programs can reveal programs known for excellence in clinical placements and strong support networks.

Cost is often a significant factor in choosing a program, so considering the cheapest online pmhnp programs can make advanced degrees more accessible without compromising quality. These pathways not only enhance clinical skills but also broaden your career potential within immunology-related healthcare fields.

Best Scientists Citing Karine Breckpot

Trending Scientists

Recently Published Articles